| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43547-431-50 | 43547-431 | HUMAN PRESCRIPTION DRUG | FENOFIBRATE | fenofibrate | TABLET | ORAL | 20190220 | N/A | ANDA | ANDA211080 | Solco Healthcare US, LLC | FENOFIBRATE | 145 mg/1 | 500 TABLET in 1 BOTTLE (43547-431-50) |
| 43547-431-09 | 43547-431 | HUMAN PRESCRIPTION DRUG | FENOFIBRATE | fenofibrate | TABLET | ORAL | 20190220 | N/A | ANDA | ANDA211080 | Solco Healthcare US, LLC | FENOFIBRATE | 145 mg/1 | 90 TABLET in 1 BOTTLE (43547-431-09) |
| 43547-430-50 | 43547-430 | HUMAN PRESCRIPTION DRUG | FENOFIBRATE | fenofibrate | TABLET | ORAL | 20190220 | N/A | ANDA | ANDA211080 | Solco Healthcare US, LLC | FENOFIBRATE | 48 mg/1 | 500 TABLET in 1 BOTTLE (43547-430-50) |
| 43547-430-09 | 43547-430 | HUMAN PRESCRIPTION DRUG | FENOFIBRATE | fenofibrate | TABLET | ORAL | 20190220 | N/A | ANDA | ANDA211080 | Solco Healthcare US, LLC | FENOFIBRATE | 48 mg/1 | 90 TABLET in 1 BOTTLE (43547-430-09) |